Related Experiment Video
Updated: Mar 15, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
New guidelines for managing pulmonary hypertension: what the pediatrician needs to know
1Pediatric Heart Lung Center, Section of Pediatric Pulmonary Medicine, Department of Pediatrics, University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Insights
New guidelines offer expert recommendations for diagnosing and evaluating pediatric pulmonary hypertension, a serious condition affecting children with various diseases. Further research is crucial for improving long-term outcomes in these young patients.
Area of Science:
- Pediatric pulmonology and cardiology
- Vascular disease in children
- Clinical guidelines development
Background:
- Pediatric pulmonary vascular disease causes significant morbidity and mortality across numerous conditions.
- Limited information exists on optimal diagnosis and evaluation strategies for pediatric pulmonary hypertension.
- Pulmonary hypertension impacts diverse pediatric diseases, including congenital heart disease and sickle cell disease.
Purpose of the Study:
- To address the need for improved diagnosis and evaluation of pediatric pulmonary hypertension.
- To highlight key topics and recommendations from newly published clinical guidelines.
- To provide guidance for practicing pediatricians and other healthcare professionals.
Main Methods:
- Formation of a multidisciplinary expert task force supported by the American Heart Association and American Thoracic Society.
- Review and synthesis of current evidence and expert clinical experience.
- Publication of joint guidelines for the care of children with pulmonary hypertension.
Main Results:
- Key topics and major recommendations for pediatric pulmonary hypertension care are presented.
- Guidelines are based on the best available evidence and expert consensus.
- The need for enhanced clinical research to improve long-term outcomes is emphasized.
Conclusions:
- The published guidelines offer a critical resource for managing pediatric pulmonary hypertension.
- Continued research is essential to advance the treatment and prognosis of pediatric pulmonary hypertension.
- Multidisciplinary collaboration is key to addressing this complex pediatric condition.
Purpose Of Review:
Pediatric pulmonary vascular disease contributes to morbidities and death in diverse clinical settings, ranging from idiopathic or heritable forms of pediatric arterial hypertension, congenital heart disease, developmental lung disorders, chronic lung disease, left heart disease, sickle cell disease, oncologic disease, and systemic disorders. Despite its impact on the clinical courses in so many diseases, information is limited on how to best approach the diagnosis and evaluation of pediatric pulmonary hypertension.
Recent Findings:
To address this issue, a group of clinical experts from several subspecialties, including pulmonology, cardiology, neonatology, and others, were selected to form a task force to tackle this topic with support from the American Heart Association and American Thoracic Society. A joint guidelines study presenting their findings was recently published.
Summary:
This review highlights a few key topics underlying guidelines for the care of children with pulmonary hypertension that are especially important for the practicing pediatrician and others, and presents some of the major recommendations from the published guidelines report. Overall, the author emphasizes that these guidelines are based on the best current evidence and clinical experience of experts in the field, yet much more clinical research is needed to improve long-term outcomes in pediatric pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

